We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Antibody Research Company Kymab Implements ConturELN
Product News

Antibody Research Company Kymab Implements ConturELN

Antibody Research Company Kymab Implements ConturELN
Product News

Antibody Research Company Kymab Implements ConturELN


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Antibody Research Company Kymab Implements ConturELN "

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Founded in 2009, Kymab is a biopharmaceutical company engaged in the discovery and development of human monoclonal antibody therapeutics. By using its proprietary KymouseTM platform, research is expected to lead to the discovery of highly potent therapeutic antibodies with excellent affinities and neutralizing capability, previously only possible through in vitro and in vivo technologies in the industry.

As a new, dynamic and fast moving company Kymab needed to adopt the most efficient methods of recording their experimental work in order to allow the rapid assessment of progress, to identify road-blocks and capitalize on the talented scientists that are part of their team.

Several Electronic Laboratory Notebook solutions were thoroughly evaluated before ConturELN was chosen, as providing the right balance between functionality with an easy learning curve and enterprise features such as IP witnessing and Oracle support etc.

“We have focused at an early stage on the ability to access and perpetuate valuable research material in an electronic format.  This will allow us to leverage our data to the best possible extent across a variety of research and development projects. Our scientists are enthusiastic about using an electronic laboratory notebook solution. Contur ELN provides an excellent balance between rich-content and usability”, says Mark Strivens, Vice President, Bioinformatics at Kymab.

“We are pleased to welcome Kymab on board as customers. This further confirms that ConturELN is an optimal solution for biopharma companies looking for a robust and secure yet user friendly and cost effective ELN solution”, says Thomas Rozlucki, CEO at Contur Software.

Advertisement